Eden Research Plc · LSE:EDEN

Eden Research — Shareholder Meeting (June 2025)

16 slides from Eden Research's shareholder meeting presentation, Jun 18, 2025

  1. Slide 1: Eden Research plc 2025 Annual General Meeting presentation

    Eden Research plc Eden Research plc is a leader in sustainable biopesticide and biocontrol technology. 2025 Annual General Meeting presentation 18 June 2025

  2. Slide 2: Executive team

    Executive team 2 Sean Smith Alex Abrey Chief Executive Officer Chief Financial Officer Over 25 years experience in the Experienced Financial Director to a speciality chemicals and industrial diverse range of businesses including biotechnology industries financial and management consultancy - 10+ yea

  3. Slide 3: Company information

    Company information 3 Key statistics Eden is the only UK quoted (AIM: EDEN) company focused on plant-derived biopesticides for sustainable agriculture Regulatory Crop uses Intellectual property and Multiple regulatory expertise in plant-derived clearances (EU, US, AUS, NZ) approvals sustainable chem

  4. Slide 4: Core business, IP & unique selling proposition

    Core business, IP & unique selling proposition 4 Eden’s focus is on developing plant-derived biopesticides using its two proprietary technology platforms: $11bn 36 The global biopesticides Number of pesticides • Plant-derived (terpene) active ingredients market is projected to banned in the EU since

  5. Slide 5: 2024 Commercial and Operational Highlights

    2024 Commercial and Operational Highlights 5 • Authorisation for Mevalone® received in the key state of California. • Mevalone® authorised for use in multiple new crops and fungal pathogens in Spain. • Authorisation for Mevalone® received in Germany and Czechia. • 140+ insecticides field trials run

  6. Slide 6: Financials

    Financials 6 • Significant increase in revenue: 2025 2024 2023 2022 • 34% vs 2023 forecast YOY % YOY % YOY % • Significant increase in product sales: £m £m £m £m change change change • 38% vs 2023 Revenue 5.0 16 4.3 34 3.2 78 1.8 • Strong financial position: Product sales 4.6 28 3.6 38 2.6 53 1.7 •

  7. Slide 7: Upcoming news-flow

    Upcoming news-flow 7 • Major label extensions for Mevalone in various countries (e.g. France) Q3, 2025 • Full approval of Ecovelex in Europe H2, 2025 • Commercial agreement(s) for insecticide H2, 2025 • Emergency Use applications for Cedroz (wireworm) and Ecovelex* H2, 2025 • Commercial agreement(s)

  8. Slide 8: Product development roadmap

    Product development roadmap 8 Late Product Target Crops/markets Discovery Early development development Partnerships Mevalone (fungicide) Botrytis, powdery High-value fruits & mildew, downy vegetables (EU, US, mildew Oceania) Cedroz (nematicide) Nematodes High-value fruits & vegetables (EU) Ecovelex

  9. Slide 9: Revenue potential by product

    Revenue potential by product 9 Total Total EU US (EU/US) (global) • Illustration based upon current €m €m €m €m and in-process labels, but ignoring future expansions of indicated uses Mevalone (botrytis) 3 3 6 15 • Peak sales generally occur 3 years Mevalone (downy mildew) 8* - 8 38 from the launch

  10. Slide 10: Key partners

    Key partners 10 Corteva Agriscience is a publicly traded agricultural company that produces seeds, crop protection products, and digital services. The company was formed in 2019 when DuPont Crop Protection, DuPont Pioneer, and Dow AgroSciences merged and in 2023 had revenue of $17bn. Established in

  11. Slide 11: Market Adoption and Regulatory Overview

    11 Market Adoption and Regulatory Overview Why do farmers use Eden’s products? - Mevalone, Cedroz and Ecovelex are all proven products - They are: - are a reliable alternative to conventional control - provide phased release for prolonged effects - are easy to use and apply - provide improved stabil

  12. Slide 12: Case Study: Late Blight Control

    Case Study: Late Blight Control 12 Plant fungal pathogens limit potential crop production and can lead to important losses in agriculture, horticulture and forestry. True fungi and fungal-like organisms consist of filamentous rows of cells called hypha which form networks called mycelium. They repro

  13. Slide 13: Case Study: Late Blight Control

    Case Study: Late Blight Control 13 Potato late blight is caused by the fungal-like (oomycete) Phytophthora infestans. It is the most serious threat to potato production, with high incidence worldwide and: § Area of 1.7 mi ha in the EU and 118K ha in the UK § £20 billion annual estimated cost globall

  14. Slide 14: Institutional and Directors' Shareholdings

    Institutional and Directors’ Shareholdings 14 % of the issued ordinary Share purchases Shareholder Number of shares share capital 2025 Gresham House Asset Management Limited 52,882,786 9.92% Octopus Investments 41,551,047 7.79% Sipcam Oxon S.p.A. 39,285,138 7.37% Canaccord Genuity Wealth Management

  15. Slide 15: Investment summary

    Investment summary 15 01 Commercialisation Eden is well-placed to further commercialise multiple products in order to 05 Increase number of commercial partners Opportunity to increase the number accelerate growth of commercial partners and diversify product range 02 Technology exploitation Ability t

  16. Slide 16: Thank you

    THANK YOU CONTACT: INFO@EDENRESEARCH.COM LSE: EDEN.L

Eden Research — Shareholder Meeting (June 2025) on 6ix